StonvexLoading…
StonvexStonvexStonvexCore line items from VSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.07B | $2.94B | $3.40B | $3.50B |
Operating Income | $56.87M | $5.63M | $486.14M | $615.49M |
Net Income | $-8.98M | $-31.15M | $323.82M | $428.81M |
EPS (Diluted) | $-0.07 | $-0.23 | $2.31 | $2.98 |
Total Assets | $4.23B | $4.11B | $4.24B | $3.87B |
Total Liabilities | $2.15B | $2.08B | $2.04B | $1.82B |
Cash & Equivalents | $514.97M | $590.29M | $972.72M | $610.83M |
Free Cash Flow OCF − CapEx | $-88.98M | $-146.38M | $36.29M | $158.98M |
Shares Outstanding | 135.74M | 136.96M | 140.25M | 143.91M |